Clonazepam Competitive Antibody Pair​

AccuSift
CZP, Clonazepam
SKU Name Unit Price Delivery QTY
SR526 Clonazepam Monoclonal Antibody 1mg $667 10 Days
TC526 Clonazepam BSA Antigen 1mg $267 10 Days

AccuSift provides high-performance competitive immunoassay antibody pairs for Clonazepam with exceptional lot-to-lot consistency. Optimized for IVD kit development (Lateral Flow, CLIA, ELISA, POCT), these antibodies offer high affinity and specificity to facilitate rapid detection.

Background:
Clonazepam is a benzodiazepine sedative. Clinically, it is primarily used for: ① Treating epilepsy and convulsions. It is effective for all types of epilepsy, especially for petit mal and myoclonic seizures. Intravenous injection is used to manage status epilepticus. ② Treating anxiety disorders and insomnia. ③ It is also effective for chorea. It provides some therapeutic benefit for drug-induced hyperactivity, chronic multiple tics, stiff-person syndrome, and various neuropathic pain conditions.

Key Characteristics:

  • Sensitivity: ELISA IC₅₀ ≈ 1 ppb; Colloidal Gold: 10 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Label)

  • Storage: Store at ≤ -20°C for long-term stability. Short-term storage at 2-8°C is acceptable. Shipped on ice packs.

Operation

References